SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
IB Acquisition Corp. Common Stock
IBAC
IB Acquisition Corp is a blank check company.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$10.87 – $10.94
Volume9
Market cap$53M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for IBAC.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for IBAC.
Recent news
Company coverage with links to the original publishers.
GNQ Insilico Inc., an AI and quantum computing-focused drug discovery company, announced a definitive business combination agreement with IB Acquisition Corp. (Nasdaq: IBAC). The transaction values GNQ at US$500 million and is expected to close in Q3 2026, with the combined company listing on Nasdaq. GNQ will provide approximately US$15 million in proceeds and has secured up to US$2 million in bridge financing.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.